Fabrication of a flower-shaped β-cyclodextrin-based Ag+ metal–organic frameworks drug delivery system and its antibacterial activity against Mycoplasma hyopneumoniae


Ma X., Chen K., Zhou Y., Lin H., She Y., Li B., ...Daha Fazla

Colloids and Surfaces A: Physicochemical and Engineering Aspects, cilt.754, 2027 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 754
  • Basım Tarihi: 2027
  • Doi Numarası: 10.1016/j.colsurfa.2026.142233
  • Dergi Adı: Colloids and Surfaces A: Physicochemical and Engineering Aspects
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Chemical Abstracts Core, Chimica, Compendex, EMBASE, INSPEC, Academic Search Ultimate (EBSCO), Engineering Source (EBSCO)
  • Anahtar Kelimeler: Antibacterial activity, Biomedical applications, Herbal compounds, Metalorganic frameworks, Stimuli-responsive drug delivery systems
  • Atatürk Üniversitesi Adresli: Evet

Özet

Rhododendron mariae Hance is a traditional medicinal plant used for the treatment of respiratory tract inflammation and contains mainly the flavonoid constituent farrerol. However, systemic drug administration results in obvious deficiencies in sustained-release performance owing to nonlinear drug release, drastic fluctuations in blood drug concentration, and a burst release effect. Herein, flower-like cyclodextrin-based metal–organic frameworks (CD-MOFs) were fabricated via an ultrasonic hydrothermal method on the basis of the structural characteristics of farrerol. β-CD-MOFs were optimally synthesized at 60 °C with a KOH/β-CD molar ratio of 8:1 and 20 mL of methanol. The Ag-modified flower-like CD-MOF-P possessed a regular crystalline morphology and excellent drug-loading capability. Multiple characterization methods, including high-performance liquid chromatography (HPLC), infrared spectroscopy (IR), and X-ray diffraction (XRD), were applied to clarify the drug adsorption mechanism, and a farrerol-loaded CD-MOF delivery system was successfully constructed. Adsorption assays confirmed that the system complied with the Elovich and Freundlich models. CD-MOF-P and CD-MOF-R achieved drug loading capacities of 352 ± 35 μg/mg and 316 ± 17 μg/mg, respectively. In vitro release tests verified Fickian diffusion-driven sustained drug release, with enhanced cumulative release under intestinal conditions. Cytotoxicity assays validated the favorable biosafety of farrerol-loaded CD-MOF-P. Moreover, this delivery system exhibited bactericidal activity against Mycoplasma hyopneumoniae M168, with an MIC of 320 μg/mL. These results highlight the great potential of naturally derived biomaterials for optimizing the delivery efficiency and therapeutic efficacy of phytochemical active ingredients and provide a sustainable and biosafe therapeutic strategy for prospective biomedical applications.